免疫性血小板减少症
医学
血液学
入射(几何)
重症监护医学
流行病学
医疗保健
人口
临床实习
协商一致会议
梅德林
人口老龄化
儿科
免疫学
家庭医学
临床免疫学
公共卫生
疾病管理
替代医学
临床研究
内科学
卫生专业人员
病历
出处
期刊:PubMed
[National Institutes of Health]
日期:2026-10-01
卷期号:65 (10): 1051-1058
标识
DOI:10.3760/cma.j.cn112138-20260313-00146
摘要
Immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder characterized by isolated thrombocytopenia. With the accelerating aging of the global population, the incidence of ITP among older adults (≥60 years) is increasing, and this population exhibits distinct epidemiological features, pathogenic mechanisms, and clinical management needs. To standardize the diagnosis and management of ITP in older adults in China, the Platelet Group of the Hematology Subcommittee of the Chinese Geriatric Society and the Hematology Subcommittee of the China International Exchange and Promotive Association for Medical and Health Care jointly established an expert consensus committee on ITP in older adults. This consensus was developed to integrate evidence-based medical data from the literature with clinical practice experience, provide practical recommendations for standardized diagnosis and treatment of geriatric ITP, and promote the conduct of future clinical research specifically targeting this population.
科研通智能强力驱动
Strongly Powered by AbleSci AI